PCDGF Inhibitors
Chemical inhibitors of PCDGF employ various mechanisms to disrupt the signaling pathways essential for the protein's activity. Picropodophyllin targets the insulin-like growth factor 1 receptor (IGF-1R), which is a critical mediator for PCDGF signaling. By inhibiting IGF-1R, Picropodophyllin prevents PCDGF from initiating the downstream effects that are necessary for its role in cellular processes. Similarly, PD168393 serves as an irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. Given that PCDGF can signal through EGFR, the inhibition by PD168393 leads to a reduction in the signaling cascades that PCDGF would typically activate. Additionally, AG490 disrupts PCDGF signaling by inhibiting Janus kinase 2 (JAK2), which is implicated in the pathways utilized by PCDGF. LY294002 and Wortmannin, both phosphatidylinositol 3-kinase (PI3K) inhibitors, directly impede the PI3K/Akt pathway, and Rapamycin specifically inhibits the mammalian target of rapamycin (mTOR), a downstream target within the same pathway, thereby collectively attenuating the signaling required for PCDGF-mediated activities.
Further inhibition strategies include targeting the mitogen-activated protein kinase (MAPK) pathways. U0126 operates by selectively inhibiting mitogen-activated protein kinase kinase (MEK), which is upstream of extracellular signal-regulated kinase (ERK), a pathway that can be leveraged by PCDGF. GW5074 inhibits Raf-1 kinase, a component of the Ras/Raf/MEK/ERK pathway, thereby blocking the downstream signaling involving PCDGF. SP600125 and SB203580 target different MAPK pathways, with SP600125 inhibiting c-Jun N-terminal kinase (JNK) and SB203580 targeting p38 MAP kinase, both of which are stress response pathways that can be activated by PCDGF. Lastly, PP2 and SU6656, both Src family tyrosine kinase inhibitors, disrupt the signaling pathways that PCDGF might activate, further contributing to the functional inhibition of this protein. Each of these inhibitors operates by obstructing specific kinases or receptors that PCDGF relies on to exert its influence on cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IGF-1R Inhibitor, PPP | 477-47-4 | sc-204008A sc-204008 sc-204008B | 1 mg 10 mg 100 mg | $138.00 $203.00 $895.00 | 63 | |
Picropodophyllin is an inhibitor of the insulin-like growth factor 1 receptor (IGF-1R) that PCDGF interacts with. By inhibiting IGF-1R, picropodophyllin can prevent PCDGF from activating downstream signaling pathways that promote cell survival and proliferation, thereby functionally inhibiting PCDGF. | ||||||
PD 168393 | 194423-15-9 | sc-222138 | 1 mg | $162.00 | 4 | |
PD168393 is an irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. PCDGF can signal through EGFR; thus, its inhibition can lead to a decrease in PCDGF-mediated signaling pathways that are dependent on EGFR activity, resulting in functional inhibition of PCDGF. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG490 is a tyrosine kinase inhibitor that can inhibit the Janus kinase 2 (JAK2), which is involved in the signaling pathways of various growth factors, including those related to PCDGF. By inhibiting JAK2, AG490 can disrupt the signaling cascade, leading to the functional inhibition of PCDGF. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is upstream of extracellular signal-regulated kinase (ERK), a pathway that PCDGF may utilize. Inhibition of MEK by U0126 can prevent the activation of ERK, thereby inhibiting PCDGF function as it relies on this pathway for some of its biological effects. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor, which blocks the PI3K/Akt pathway, a critical signaling pathway for many growth factors including PCDGF. Inhibition of this pathway by LY294002 can reduce PCDGF signaling, leading to a functional inhibition of PCDGF. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a specific inhibitor of the mammalian target of rapamycin (mTOR), a downstream component of the PI3K/Akt pathway, which PCDGF may affect. By inhibiting mTOR, rapamycin can inhibit the signaling required for PCDGF-mediated cellular processes such as growth and proliferation. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is an inhibitor of Raf-1 kinase, a part of the Ras/Raf/MEK/ERK pathway, which PCDGF can activate. By inhibiting Raf-1 kinase, GW5074 can block the downstream signaling that contributes to the functional activity of PCDGF. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is involved in stress response pathways and can be activated by PCDGF. Inhibition of JNK by SP600125 can lead to functional inhibition of PCDGF by preventing it from exerting its effects through JNK-mediated signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase, which is another stress response pathway potentially utilized by PCDGF. By inhibiting p38 MAP kinase, SB203580 can functionally inhibit PCDGF by blocking its ability to signal through this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K, similar to LY294002, and by inhibiting this kinase it can affect the PI3K/Akt pathway crucial for PCDGF signaling. Thus, wortmannin can functionally inhibit PCDGF by impeding a key pathway it utilizes. | ||||||